J&J to supply 200 million Covid-19 vaccine doses to EU

The potential Covid-19 vaccine is being developed by J&J subsidiary, Janssen Pharmaceutical, which will be responsible for the supply. Credit: pearson0612 from Pixabay.



  • J&J; vaccine